Cargando…

Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive

Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores rep...

Descripción completa

Detalles Bibliográficos
Autor principal: Hohmann, Heather
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778430/
https://www.ncbi.nlm.nih.gov/pubmed/19936163
_version_ 1782174245833408512
author Hohmann, Heather
author_facet Hohmann, Heather
author_sort Hohmann, Heather
collection PubMed
description Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores reported for this method are similar to other long-acting reversible contraception as well as similar to sterilization. The implant has been shown to be safe during breast feeding and may improve symptoms of dysmenorrhea and endometriosis. Irregular bleeding patterns can be expected with the device’s use and should be addressed in order to decrease rates of discontinuation.
format Text
id pubmed-2778430
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27784302009-11-23 Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive Hohmann, Heather Patient Prefer Adherence Review Contraceptive implants provide long-acting, highly effective reversible contraception. The etonogestrel implant (ENG implant) is a single rod implant that offers three years of efficacy. The ENG implant was designed to provide contraceptive efficacy by inhibiting ovulation and Pearl Index scores reported for this method are similar to other long-acting reversible contraception as well as similar to sterilization. The implant has been shown to be safe during breast feeding and may improve symptoms of dysmenorrhea and endometriosis. Irregular bleeding patterns can be expected with the device’s use and should be addressed in order to decrease rates of discontinuation. Dove Medical Press 2009-11-03 /pmc/articles/PMC2778430/ /pubmed/19936163 Text en © 2009 Hohmann, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Hohmann, Heather
Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
title Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
title_full Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
title_fullStr Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
title_full_unstemmed Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
title_short Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
title_sort examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778430/
https://www.ncbi.nlm.nih.gov/pubmed/19936163
work_keys_str_mv AT hohmannheather examiningtheefficacysafetyandpatientacceptabilityoftheetonogestrelimplantablecontraceptive